Prognostic usefulness of lymphocyte V beta receptor determination in toxic shock syndrome.
Ohashi
Reiko
R
Department of Paediatrics, Kansai Medical University, 10-15 Fumizonocho, Moriguchi, 570-8506 Osaka, Japan.
Takaya
Junji
J
Tsuji
Shoji
S
Yamato
Fumiko
F
Hasui
Masafumi
M
Kinoshita
Yoh
Y
Kobayashi
Yohnosuke
Y
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002056:Burns / Q000150:complications / Q000601:surgery; D005260:Female; D005334:Fever / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D006801:Humans; D007223:Infant; D008214:Lymphocytes / Q000276:immunology*; D011379:Prognosis; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000097:blood*; D012772:Shock, Septic / Q000097:blood / Q000150:complications / Q000175:diagnosis*; D016038:Skin Transplantation; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D016693:Receptors, Antigen, T-Cell, alpha-beta